These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10995395)

  • 1. Apoptosis: a pivotal event or an epiphenomenon in the pathophysiology of heart failure?
    Marshall D; Sack MN
    Heart; 2000 Oct; 84(4):355-6. PubMed ID: 10995395
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure.
    Guazzi M
    Circ Heart Fail; 2008 Nov; 1(4):272-80. PubMed ID: 19808302
    [No Abstract]   [Full Text] [Related]  

  • 3. New inotropic drugs for treatment of congestive heart failure.
    Schwertz DW; Piano MR
    Cardiovasc Nurs; 1990; 26(2):7-12; discussion 12. PubMed ID: 1969769
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure.
    Van Tassell BW; Radwanski P; Movsesian M; Munger MA
    Pharmacotherapy; 2008 Dec; 28(12):1523-30. PubMed ID: 19025433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.
    Skudicky D; Sliwa K; Bergemann A; Candy G; Sareli P
    Heart; 2000 Oct; 84(4):438-9. PubMed ID: 10995419
    [No Abstract]   [Full Text] [Related]  

  • 6. Pentoxifylline in sepsis.
    Maier RV
    Arch Surg; 1998 Apr; 133(4):466. PubMed ID: 9565133
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms and clinical profile of inotropic action of medicines for heart failure].
    Yazaki Y
    Kokyu To Junkan; 1989 Dec; 37(12):1271-7. PubMed ID: 2694254
    [No Abstract]   [Full Text] [Related]  

  • 8. Pentoxifylline: Evidence strong enough for renoprotection?
    Lai TS; Chiang WC; Chen YM
    J Formos Med Assoc; 2016 Aug; 115(8):591-2. PubMed ID: 26817833
    [No Abstract]   [Full Text] [Related]  

  • 9. [Future aspects of new cardiotonic drugs].
    Hori M; Sato H; Kamata T
    Nihon Naika Gakkai Zasshi; 1994 Jan; 83(1):59-63. PubMed ID: 9132455
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phosphodiesterase inhibitors--a new therapeutic principle in heart failure].
    Erhardt L
    Lakartidningen; 1988 Nov; 85(44):3662-3. PubMed ID: 3199999
    [No Abstract]   [Full Text] [Related]  

  • 11. Theory and practice in the treatment of heart failure.
    Taylor SH
    G Ital Cardiol; 1979; 9(5):507-26. PubMed ID: 478222
    [No Abstract]   [Full Text] [Related]  

  • 12. Pentoxifylline attenuates reperfusion injury in skeletal muscle after partial ischemia.
    Kishi M; Tanaka H; Seiyama A; Takaoka M; Matsuoka T; Yoshioka T; Sugimoto H
    Am J Physiol; 1998 May; 274(5):H1435-42. PubMed ID: 9612347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure: therapeutic challenges and strategies and the role of phosphodiesterase inhibitors. 31 August 1988, Vienna, Austria.
    Eur Heart J; 1989 Aug; 10 Suppl C():1-59. PubMed ID: 2806285
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective effects of pentoxifylline on the brain following remote burn injury.
    Ji Q; Jia H; Dai H; Li W; Zhang L
    Burns; 2010 Dec; 36(8):1300-8. PubMed ID: 20573453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial.
    Joshi P; Manori P; Bajpai P
    J Assoc Physicians India; 2013 May; 61(5):354. PubMed ID: 24482957
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current role of non-digitalis inotropic agents in acute and chronic treatment of heart failure].
    Dei Cas L; Nodari S; Raddino R; Metra M; Pelà G; Nardi M
    Cardiologia; 1994 Mar; 39(3):209-15. PubMed ID: 8039201
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases.
    Anaya JM; Espinoza LR
    J Rheumatol; 1995 Apr; 22(4):595-9. PubMed ID: 7791149
    [No Abstract]   [Full Text] [Related]  

  • 18. Atherosclerosis and pentoxifylline. Proceedings of an international symposium. Prague, 10-12 October 1996.
    Atherosclerosis; 1997 Jun; 131 Suppl():S1-41. PubMed ID: 9290055
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent aphthous stomatitis: treatment with pentoxifylline.
    Pizarro A; Herranz P; Navarro A; Casado M
    Acta Derm Venereol; 1996 Jan; 76(1):79-80. PubMed ID: 8721504
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of heart failure in children].
    Pipitone S; Manetti A
    G Ital Cardiol; 1995 Nov; 25(11):1485-90. PubMed ID: 8682250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.